Advertisement

Urinary Incontinence

  • Priya Padmanabhan
  • Roger Dmochowski
Chapter
Part of the Springer Specialist Surgery Series book series (SPECIALIST)

Abstract

Urinary incontinence (UI) or the involuntary leakage of urine is a distressing and serious health problem. Its psychosocial and economic burden leads to significant quality of life issues. The prevalence of urinary incontinence (UI) differs by type, etiology, gender, age, and distribution1 (see Fig. 32.1). The three most common types of UI are stress urinary incontinence (SUI), urge urinary incontinence (UUI), or a combination of both, mixed urinary incontinence (MUI). The International Continence Society (ICS) defines SUI as involuntary leakage on effort or exertion, or on sneezing or coughing. UUI refers to involuntary leakage accompanied or immediately preceded by urgency. MUI is defined as a complaint of involuntary leakage associated with urgency and also with exertion, effort, sneezing, or coughing.3 UI is a manifestation of different types of injury and disease processes of the lower urinary tract or the nervous system that regulates it.4 This chapter describes the epidemiology, economics, and pathophysiology of incontinence. The importance of a proper work-up for accurate diagnosis is included. Conservative, pharmacological, and surgical therapy for women and men is delineated.

Keywords

Urinary Incontinence Stress Urinary Incontinence Urge Urinary Incontinence Pelvic Floor Muscle Training Sacral Nerve Stimulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hunskaar S, Arnold EP, Burgio K, et al. Epidemiology and natural history of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11:301PubMedCrossRefGoogle Scholar
  2. 2.
    Wein AJ, Rackley RR. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol. 2006;175:S5PubMedCrossRefGoogle Scholar
  3. 3.
    Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37PubMedCrossRefGoogle Scholar
  4. 4.
    Athanasopoulos A, Perimenis P. Pharmacotherapy of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;20(4):475-482PubMedGoogle Scholar
  5. 5.
    Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the third national health and nutrition examination survey, 1988–1991. Hypertension. 1995;25:305PubMedGoogle Scholar
  6. 6.
    Silverstein B. Gender difference in the prevalence of clinical depression: the role played by depression associated with somatic symptoms. Am J Psychiatry. 1999;156:480PubMedGoogle Scholar
  7. 7.
    Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diab Care. 2004;27:1047CrossRefGoogle Scholar
  8. 8.
    Odeyemi IA, Dakin HA, O’Donnell RA, et al. Epidemiology, prescribing patterns and resource use associated with overactive bladder in UK primary care. Int J Clin Pract. 2006;60:949PubMedCrossRefGoogle Scholar
  9. 9.
    Hannestad YS, Rortveit G, Sandvik H, et al. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of incontinence in the county of nord-trondelag. J Clin Epidemiol. 2000;53:1150PubMedCrossRefGoogle Scholar
  10. 10.
    Hunskaar S, Burgio K, Diokno AC, et al. Epidemiology and natural history of urinary incontinence. In: Abrams P, Cardozo L, Khoury S, WEin A, eds. Incontinence. 2nd ed. Plymouth, UK: Health Publication Ltd.; 2002:165Google Scholar
  11. 11.
    Tennstedt SL, Link CL, Steers WD, et al. Prevalence of and risk factors for urine leakage in a racially and ethnically diverse population of adults: the Boston Area Community Health (BACH) survey. Am J Epidemiol. 2008;167:390PubMedCrossRefGoogle Scholar
  12. 12.
    Wilson MM. Urinary incontinence: selected current concepts. Med Clin North Am. 2006;90:825PubMedCrossRefGoogle Scholar
  13. 13.
    Klauser A, Frauscher F, Strasser H, et al. Age-related rhabdosphincter function in female urinary stress incontinence: assessment of intraurethral sonography. J Ultrasound Med. 2004;23:631PubMedGoogle Scholar
  14. 14.
    Lluel P, Deplanne V, Heudes D, et al. Age-related changes in urethrovesical coordination in male rats: relationship with bladder instability? Am J Physiol Regul Integr Comp Physiol. 2003;284:R1287PubMedGoogle Scholar
  15. 15.
    Patel MD, Coshall C, Rudd AG, et al. Cognitive impairment after stroke: clinical determinants and its associations with long-term stroke outcomes. J Am Geriatr Soc. 2002;50:700PubMedCrossRefGoogle Scholar
  16. 16.
    Yoshida M, Miyamae K, Iwashita H, et al. Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology. 2004;63:17PubMedCrossRefGoogle Scholar
  17. 17.
    Klausner AP, Vapnek JM. Urinary incontinence in the geriatric population. Mt Sinai J Med. 2003;70:54PubMedGoogle Scholar
  18. 18.
    Landi F, Cesari M, Russo A, et al. Potentially reversible risk factors and urinary incontinence in frail older people living in community. Age Ageing. 2003;32:194PubMedCrossRefGoogle Scholar
  19. 19.
    McLoughlin MA, Chew DJ. Diagnosis and surgical management of ectopic ureters. Clin Tech Small Anim Pract. 2000;15:17PubMedCrossRefGoogle Scholar
  20. 20.
    Ouslander JG. Intractable incontinence in the elderly. BJU Int. 2000;85(3):72PubMedGoogle Scholar
  21. 21.
    Zunzunegui Pastor MV, Rodriguez-Laso A, Garcia Yebenes MJ, et al. Prevalence of urinary incontinence and linked factors in men and women over 65. Aten Primaria. 2003;32:337PubMedGoogle Scholar
  22. 22.
    Bradway C. Urinary incontinence among older women. Measurement of the effect on health-related quality of life. J Gerontol Nurs. 2003;29:13PubMedGoogle Scholar
  23. 23.
    Hogan DB. Revisiting the O complex: urinary incontinence, delirium and polypharmacy in elderly patients. CMAJ. 1997;157:1071PubMedGoogle Scholar
  24. 24.
    Johansson C, Hellstrom L, Ekelund P, et al. Urinary incontinence: a minor risk factor for hip fractures in elderly women. Maturitas. 1996;25:21PubMedCrossRefGoogle Scholar
  25. 25.
    Saltvedt I, Mo ES, Fayers P, et al. Reduced mortality in treating acutely sick, frail older patients in a geriatric evaluation and management unit. A prospective randomized trial. J Am Geriatr Soc. 2002;50:792PubMedCrossRefGoogle Scholar
  26. 26.
    Baztan JJ, Arias E, Gonzalez N, et al. New-onset urinary incontinence and rehabilitation outcomes in frail older patients. Age Ageing. 2005;34:172PubMedCrossRefGoogle Scholar
  27. 27.
    Miner PB Jr. Economic and personal impact of fecal and urinary incontinence. Gastroenterology. 2004;126:S8PubMedCrossRefGoogle Scholar
  28. 28.
    Brading AF. A myogenic basis for the overactive bladder. Urology. 1997;50:57PubMedCrossRefGoogle Scholar
  29. 29.
    Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity. J Urol. 1993;150:1668PubMedGoogle Scholar
  30. 30.
    Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction. IV. Bladder outlet obstruction. J Urol. 1993;150:1681PubMedGoogle Scholar
  31. 31.
    de Groat WC. A neurologic basis for the overactive bladder. Urology. 1997;50:36PubMedCrossRefGoogle Scholar
  32. 32.
    Drake MJ, Mills IW, Gillespie JI. Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function. Lancet. 2001;358:401PubMedCrossRefGoogle Scholar
  33. 33.
    Andersson KE, Appell R, Cardozo LD, et al. The pharmacological treatment of urinary incontinence. BJU Int. 1999;84:923PubMedCrossRefGoogle Scholar
  34. 34.
    Hashim H, Abrams P. Overactive bladder: an update. Curr Opin Urol. 2007;17:231PubMedCrossRefGoogle Scholar
  35. 35.
    Andersson KE, Pehrson R. CNS involvement in overactive bladder. Drugs. 2003;63:2595PubMedCrossRefGoogle Scholar
  36. 36.
    Cardozo L. New developments in the management of stress urinary incontinence. BJU Int. 2004;94(1):1PubMedCrossRefGoogle Scholar
  37. 37.
    Mostwin JL. Urinary incontinence. J Urol. 1995;153:352PubMedCrossRefGoogle Scholar
  38. 38.
    Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol. 1994;152:1831PubMedGoogle Scholar
  39. 39.
    Leach GE, Trockman B, Wong A, et al. Post-prostatectomy incontinence: urodynamic findings and treatment outcomes. J Urol. 1996;155:1256PubMedCrossRefGoogle Scholar
  40. 40.
    Groutz A, Blaivas JG, Chaikin DC, et al. The pathophysiology of post-radical prostatectomy incontinence: a clinical and video urodynamic study. J Urol. 2000;163:1767PubMedCrossRefGoogle Scholar
  41. 41.
    Coyne KS, Margolis MK, Thompson C, et al. Psychometric equivalence of the OAB-q in Danish, German, Polish, Swedish and Turkish. Int Soc Pharmacoeconomics Outcomes Res ISPOR. 2008;11(7):1096Google Scholar
  42. 42.
    Brown JS, McNaughton KS, Wyman JF, et al. Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology. 2003; 61:802PubMedCrossRefGoogle Scholar
  43. 43.
    Ku JH, Jeong IG, Lim DJ, et al. Voiding diary for the evaluation of urinary incontinence and lower urinary tract symptoms: prospective assessment of patient compliance and burden. Neurourol Urodyn. 2004;23:331PubMedCrossRefGoogle Scholar
  44. 44.
    Nygaard I, Holcomb R. Reproducibility of the seven-day voiding diary in women with stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11:15PubMedCrossRefGoogle Scholar
  45. 45.
    Fletcher SG, Lemack GE. Clarifying the role of urodynamics in the preoperative evaluation of stress urinary incontinence. ScientificWorld J. 2008;8:1259CrossRefGoogle Scholar
  46. 46.
    Patel AK, Chapple CR. Urodynamics in the management of female stress incontinence – which test and when? Curr Opin Urol. 2008;18:359PubMedCrossRefGoogle Scholar
  47. 47.
    Lemack GE, Xu Y, Brubaker L, et al. Clinical and demographic factors associated with valsalva leak point pressure among women undergoing burch bladder neck suspension or autologous rectus fascial sling procedures. Neurourol Urodyn. 2007;26:392PubMedCrossRefGoogle Scholar
  48. 48.
    Comiter CV. Surgery Insight: surgical management of postprostatectomy incontinence – the artificial urinary sphincter and male sling. Nat Clin Pract Urol. 2007;4:615PubMedCrossRefGoogle Scholar
  49. 49.
    Nager CW, FitzGerald M, Kraus SR, et al. Urodynamic measures do not predict stress continence outcomes after surgery for stress urinary incontinence in selected women. J Urol. 2008;179:1470PubMedCrossRefGoogle Scholar
  50. 50.
    Paick JS, Oh SJ, Kim SW, et al. Tension-free vaginal tape, suprapubic arc sling, and transobturator tape in the treatment of mixed urinary incontinence in women. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:123PubMedGoogle Scholar
  51. 51.
    Burgio KL. Current perspectives on management of urgency using bladder and behavioral training. J Am Acad Nurse Pract. 2004;16:4PubMedGoogle Scholar
  52. 52.
    Andersson KE. Antimuscarinics for treatment of overactive bladder. Lancet Neurol. 2004;3:46PubMedCrossRefGoogle Scholar
  53. 53.
    Anderson RU, MacDiarmid S, Kell S, et al. Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17:502PubMedCrossRefGoogle Scholar
  54. 54.
    Chapple CR, Martinez-Garcia R, Selvaggi L, et al. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: Results of the STAR trial. Eur Urol. 2005;48:464PubMedCrossRefGoogle Scholar
  55. 55.
    Haab F, Stewart L, Dwyer P. Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder. Eur Urol. 2004;45:420PubMedCrossRefGoogle Scholar
  56. 56.
    Chancellor MB, de Groat WC. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol. 1999;162:3PubMedCrossRefGoogle Scholar
  57. 57.
    Holzer-Petsche U, Lembeck F. Systemic capsaicin treatment impairs the micturition reflex in the rat. Br J Pharmacol. 1984;83:935PubMedGoogle Scholar
  58. 58.
    Kawatani M, Whitney T, Booth AM, et al. Excitatory effect of substance P in parasympathetic ganglia of cat urinary bladder. Am J Physiol. 1989;257:R1450PubMedGoogle Scholar
  59. 59.
    Yoshimura N, Erdman SL, Snider MW, et al. Effects of spinal cord injury on neurofilament immunoreactivity and capsaicin sensitivity in rat dorsal root ganglion neurons innervating the urinary bladder. Neuroscience. 1998;83:633PubMedCrossRefGoogle Scholar
  60. 60.
    Fowler CJ, Beck RO, Gerrard S, et al. Intravesical capsaicin for treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry. 1994;57:169PubMedCrossRefGoogle Scholar
  61. 61.
    Kim JH, Rivas DA, Shenot PJ, et al. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial. J Spinal Cord Med. 2003;26:358PubMedGoogle Scholar
  62. 62.
    Apostolidis A, Popat R, Yiangou Y, et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol. 2005;174:977PubMedCrossRefGoogle Scholar
  63. 63.
    Dmochowski R, Sand PK. Botulinum toxin A in the overactive bladder: current status and future directions. BJU Int. 2007;99:247PubMedCrossRefGoogle Scholar
  64. 64.
    Brubaker L, Richter HE, Visco A, et al. Refractory idiopathic urge urinary incontinence and botulinum a injection. J Urol. 2008;180:217PubMedCrossRefGoogle Scholar
  65. 65.
    van Kerrebroeck PEV, van Voskuilen AC, Heesakkers JPFA, Nijholt AABL, Siegel S, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of prospective, worldwide clinical study. J Urol. 2007;178:2029PubMedCrossRefGoogle Scholar
  66. 66.
    Sutherland SE, Lavers A, Carlson A, Holtz C, Kesha J, Siegel SW. Sacral nerve stimulation for voiding dysfunction: one institution’s 11-year experience. Neurourol Urodyn. 2007;26:19PubMedCrossRefGoogle Scholar
  67. 67.
    Cooperberg MR, Stoller ML. Posterior tibial nerve stimulation for pelvic floor dysfunction. In: Raz S, Larissa V, eds. Female Urology. 3rd ed. Philadelphia, PA: Saunders Elsevier; 2008Google Scholar
  68. 68.
    Parekh AR, Feng MI, Kirages D, Bremner H, et al. The role of pelvic floor exercises on post-prostatectomy incontinence. J Urol. 2003;170:130PubMedCrossRefGoogle Scholar
  69. 69.
    Tiguert R et al. Collagen injection in the management of post-radical retropubic prostatectomy intrinsic sphincteric deficiency. Neurourol Urodyn. 1999;18:653PubMedCrossRefGoogle Scholar
  70. 70.
    Smith DN et al. Collagen injection therapy for post-prostatectomy incontinence. J Urol. 1998;160:364PubMedCrossRefGoogle Scholar
  71. 71.
    Sanchez-Ortiz RF et al. Collagen injection therapy for post-radical retropubic prostatectomy incontinence: role of valsalva leak point pressure. J Urol. 1997;158:2132PubMedCrossRefGoogle Scholar
  72. 72.
    Comiter CV. Surgery insight: surgical management of postprostatecotmy incontinence- the artificial urinary sphincter and male sling. Nature. 2007;4:615Google Scholar
  73. 73.
    Montague DK, Angermeier KW. Postprostatectomy urinary incontinence: the case for artificial urinary sphincter implantation. Urology. 2000;55:2PubMedCrossRefGoogle Scholar
  74. 74.
    Litwiller SE et al. Post-prostatectomy iIncontinence and the artificial urinary sphincter: a long-term study of patient satisfaction and criteria for success. J Urol. 1996;156(6):1975-1980PubMedCrossRefGoogle Scholar
  75. 75.
    Petrou SP et al. Artificial urinary sphincter for incontinence. Urology. 2000;56:353PubMedCrossRefGoogle Scholar
  76. 76.
    Fulford SC et al. The fate of the “modern” artificial urinary sphincter with a follow-up of more than 10 Years. Br J Urol. 1997;79:713PubMedGoogle Scholar
  77. 77.
    Montague DK. The artificial urinary sphincter (AMS 800): experience in 166 consecutive patients. J Urol. 1992;147:380PubMedGoogle Scholar
  78. 78.
    Elliott DS, Barrett DM. May clinic long-term analysis of the functional durability of the AMS 800 artificial urinary sphincter: a review of the 323 cases. J Urol. 1998;159:1206PubMedCrossRefGoogle Scholar
  79. 79.
    Comiter CV. The male perineal sling: intermediate-term results. Neurourol Urodyn. 2005;24:648PubMedCrossRefGoogle Scholar
  80. 80.
    Rajpurkar AD et al. Patient satisfaction and clinical efficacy of the new perineal bone-anchored male sling. Eur Urol. 2005;47:237PubMedCrossRefGoogle Scholar
  81. 81.
    Rehder P, Gozzi C. Transobturator sling suspension for male urinary incontinence including post-radical prostatectomy. Eur Urol. 2007;52:860PubMedCrossRefGoogle Scholar
  82. 82.
    Pesce F. Current management of stress urinary incontinence. BJU Int. 2004;94:8PubMedCrossRefGoogle Scholar
  83. 83.
    Rovner ES, Wein AJ. Treatment options for stress urinary incontinence. Rev Urol. 2004;6:S29PubMedGoogle Scholar
  84. 84.
    Wyman JF, Fantl JA, McClish DK, Bump RC. For the continence program for women research group. Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Am J Obstet Gynecol. 1998;179:999PubMedCrossRefGoogle Scholar
  85. 85.
    Wilson PD, Bo K, Hay-Smith J, et al. Conservative treatment in women. In: Abrams P, Cardozo L, Khoury S, Wein A, eds. Incontinence. 2nd ed. Plymouth, UK: Health Publication Ltd.; 2002:571-624Google Scholar
  86. 86.
    Agency for Health Care Policy and Research, US Department of Health and Human Services. Clinical Practice Guidelines: Urinary Incontinence in Adults. Rockville, MD: Agency for Health Care Policy and Research; 1992. AHCPR Publication 92–0038Google Scholar
  87. 87.
    Lin HH, Sheu BC, Lo MC, Huang SC. Comparison of treatment outcomes for imipramine for female genuine stress incontinence. Br J Obstet Gynaecol. 1999;106:1089PubMedCrossRefGoogle Scholar
  88. 88.
    Basu M, Duckett J. The treatment of urinary incontinence with Duloxetine. J Obstet Gynaecol. 2008;28:166PubMedCrossRefGoogle Scholar
  89. 89.
    Vella M, Duckett J, Basu M. Duloxetine 1 year on: the long-term outcome of a cohort of women prescribed duloxetine. Int Urogynecol J. 2008;19:961CrossRefGoogle Scholar
  90. 90.
    Yasuda K, Kawabe K, Takimoto Y, The Clenbuterol Clinical Research Group, et al. A double-blind clinical trial of a ß2-adrenergic agonist in stress incontinence. Int Urogynecol J. 1993;4:146CrossRefGoogle Scholar
  91. 91.
    Rogers RG. Urinary stress incontinence in women. N Engl J Med. 2008;358:1029-1036PubMedCrossRefGoogle Scholar
  92. 92.
    Abrams P, Cardozo L, Khoury S, Wein A, eds. Incontinence. 2nd ed. Plymouth, UK: Health Publication Ltd.; 2002Google Scholar
  93. 93.
    Leach GE, Dmochowski RR, Appell RA, et al. Female stress urinary incontinence clinical guidelines panel summary report on surgical management of female stress urinary incontinence. J Urol. 1997;158:875PubMedCrossRefGoogle Scholar
  94. 94.
    Ward KL, Hilton P. UK and Ireland TVT trial group. A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence: 2-year follow-up. Am J Obstet Gynecol. 2004;190:324PubMedCrossRefGoogle Scholar
  95. 95.
    Wang W, Zhu L, Lang J. Transobturator tape procedure versus tension-free vaginal tape for treatment of stress urinary incontinence. Int J Gynaecol Obstet. 2009;104(2):113-116PubMedCrossRefGoogle Scholar
  96. 96.
    Schulz JA, Chan MC, Farrell SA. The sub-committee on urogynaecology. Midurethral minimally invasive sling procedures for stress. Urin Incontin. 2008;213:728Google Scholar
  97. 97.
    Molden SM, Lucente VR. New minimally invasive slings: TVT Secur. Curr Urol Rep. 2008;9:358PubMedCrossRefGoogle Scholar
  98. 98.
    Zimmern PE, Hadley HR, Leach GE, et al. Female urethral obstruction after Marshall-Marchetti-Krantz operation. J Urol. 1987;138:517PubMedGoogle Scholar
  99. 99.
    Dooley Y, Lowenstein L, Kenton K, et al. Mixed incontinence is more bother than pure incontinence subtypes. Int Urogynecol J. 2008;19:1359CrossRefGoogle Scholar
  100. 100.
    Khullar V, Hill S, Laval KU, Schiotz HA, et al. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Urology. 2004;64:269PubMedCrossRefGoogle Scholar

Copyright information

© Springer London 2011

Authors and Affiliations

  • Priya Padmanabhan
    • 1
  • Roger Dmochowski
    • 2
  1. 1.Female Urology and Reconstructive SurgeryUniversity of Kansas Medical CenterKansas CityUSA
  2. 2.Department of UrologyVanderbilt University Medical CenterNashvilleUSA

Personalised recommendations